1. Three Cases of Anaplastic Thyroid Carcinoma Transformation and Leukocytosis during Lenvatinib Treatment
   Hiroyuki Iwasaki et al, 2020, Case Reports in Endocrinology CrossRef
2. Low Dose of Lenvatinib Treatment for Patients of Radioiodine-Refractory Differentiated Thyroid Carcinoma – A Real-World Experience
   He-Jiun Jiang et al, 2021, Cancer Management and Research CrossRef
3. Efficacy of anlotinib combined with radioiodine to treat scalp metastasis of papillary thyroid cancer: A case report and review of literature
   Li-Yong Zhang et al, 2023, World Journal of Clinical Cases CrossRef
4. Multikinase Inhibitor Treatment in Thyroid Cancer
   Ole Vincent Ancker et al, 2019, International Journal of Molecular Sciences CrossRef
5. Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with PTEN mutation: a case report and literature review
   Youjin Oh et al, 2024, Frontiers in Endocrinology CrossRef